160 related articles for article (PubMed ID: 7617857)
1. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.
Laya MB; Gallagher JC; Schreiman JS; Larson EB; Watson P; Weinstein L
Radiology; 1995 Aug; 196(2):433-7. PubMed ID: 7617857
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone therapy and mammographic breast density.
Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone therapy and change in mammographic density.
Greendale GA; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Ursin G
J Natl Cancer Inst; 2003 Jan; 95(1):30-7. PubMed ID: 12509398
[TBL] [Abstract][Full Text] [Related]
5. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
[TBL] [Abstract][Full Text] [Related]
6. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.
Greendale GA; Reboussin BA; Sie A; Singh HR; Olson LK; Gatewood O; Bassett LW; Wasilauskas C; Bush T; Barrett-Connor E
Ann Intern Med; 1999 Feb; 130(4 Pt 1):262-9. PubMed ID: 10068383
[TBL] [Abstract][Full Text] [Related]
7. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
Georgiev DB; Manassiev NA
Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
[TBL] [Abstract][Full Text] [Related]
8. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
[TBL] [Abstract][Full Text] [Related]
9. Mammographic density increase in women receiving different hormone replacement regimens.
Erel CT; Esen G; Seyisoglu H; Elter K; Uras C; Ertungealp E; Aksu MF
Maturitas; 2001 Nov; 40(2):151-7. PubMed ID: 11716993
[TBL] [Abstract][Full Text] [Related]
10. Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
Byrne C; Ursin G; Martin CF; Peck JD; Cole EB; Zeng D; Kim E; Yaffe MD; Boyd NF; Heiss G; McTiernan A; Chlebowski RT; Lane DS; Manson JE; Wactawski-Wende J; Pisano ED
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376149
[TBL] [Abstract][Full Text] [Related]
11. Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy.
Crandall CJ; Karlamangla A; Huang MH; Ursin G; Guan M; Greendale GA
Arch Intern Med; 2006 Aug 14-28; 166(15):1578-84. PubMed ID: 16908790
[TBL] [Abstract][Full Text] [Related]
12. The effect of low dose hormone therapy on mammographic breast density.
Christodoulakos GE; Lambrinoudaki IV; Vourtsi AD; Vlachou S; Creatsa M; Panoulis KP; Botsis D
Maturitas; 2006 Apr; 54(1):78-85. PubMed ID: 16198519
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
[TBL] [Abstract][Full Text] [Related]
14. [Effects of hormonal replacement therapy on breast density in postmenopausal women].
Bisanti T; Cavalieri AP; Capri O; Galoppi P; De Felice C; Porfiri LM; Perrone G
Minerva Ginecol; 2004 Apr; 56(2):125-30. PubMed ID: 15258540
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
Topal NB; Ayhan S; Topal U; Bilgin T
J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
[TBL] [Abstract][Full Text] [Related]
16. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study.
McNicholas MM; Heneghan JP; Milner MH; Tunney T; Hourihane JB; MacErlaine DP
AJR Am J Roentgenol; 1994 Aug; 163(2):311-5. PubMed ID: 8037021
[TBL] [Abstract][Full Text] [Related]
17. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo.
Freedman M; San Martin J; O'Gorman J; Eckert S; Lippman ME; Lo SC; Walls EL; Zeng J
J Natl Cancer Inst; 2001 Jan; 93(1):51-6. PubMed ID: 11136842
[TBL] [Abstract][Full Text] [Related]
18. [Effect of hormone replacement therapy on the mammographic density of the female breast].
Egyed Z; Péntek Z; Magyar Z
Magy Onkol; 2005; 49(4):319-21, 323-5. PubMed ID: 16518476
[TBL] [Abstract][Full Text] [Related]
19. Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment.
Gram IT; Ursin G; Spicer DV; Pike MC
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1117-20. PubMed ID: 11700258
[TBL] [Abstract][Full Text] [Related]
20. [A mammographic evaluation of the morphostructural variations of the breast during hormone-replacement therapy in the postmenopause].
Porfiri LM; Costanza L; De Felice C; Perrone G; David V; Zichella L
Radiol Med; 1998 Jun; 95(6):573-6. PubMed ID: 9717537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]